CD4 and Friedreich ataxia: We have previously demonstrated that kakkonto suppresses the occurrence of allergic symptoms in a murine FA model [21] and kakkonto induces Foxp3+ CD4+ regulatory T cells (Tregs) in the colon as a novel mechanism underlying the therapeutic action [22].